Drawing for QIAGEN QUALITY

USPTO serial 79045657

QIAGEN QUALITY

Reviewed by CopyMark Law Group

Reg. 3520849Status 706Registered
Filing date
Status date
Registration date
Oct 21, 2008
Examiner
MARTIN, EUGENIA K
Law office
GENERIC WEB UPDATE

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with QIAGEN QUALITY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Victoria Friedman

Victoria Friedman Dennemeyer & Associates, LLC.2 North Riverside Plaza, Suite 1500Chicago, IL 60606UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001[ Chemical, biochemical and biotechnological products for industrial and scientific purposes, in particular nucleic acids, enzymes, polymerases, reagents for staining and marking, molecular probes, buffer, aqueous and non-aqueous solutions of alcohols and salts, distilled and purified water, silica in powdered, granulate and gel form and magnetic particles in fluid form, none of the foregoing for medical or veterinary purposes; Materials for columns and reagents and solvents for sample preparation, all of the foregoing for the purpose of purification, lysis, modification and manipulation of cells, as well as for the performance of marking, separation, isolation, purification, amplification and analytical methods for biopolymers, in particular nucleic acids, enzymes, proteins, macro molecules and biologically active substances for separation, analysis and purification of biological and biochemical compounds, none of the foregoing for medical or veterinary purposes; ] Kits comprising chemical, biochemical and biotechnological products for sample preparation, purification, lysis, modification and manipulation of cells as well as for the performance of marking, separation, isolation, purification, amplification and analytical methods for biopolymers, in particular nucleic acids, enzymes, proteins, macro molecules and biologically active substances for separation, analysis and purification of biological and biochemical compounds, in particular nucleic acids made from biological and biochemical sample material, none of the foregoing for medical or veterinary purposesACTIVE—
005[ Products for medical and veterinary medical purposes, in particular diagnostic preparations, in particular nucleic acids, enzymes, polymerases, reagents for staining and marking, molecular probes, buffer chemicals and aqueous and non-aqueous solutions of primary, secondary and tertiary alcohols and salts, distilled and purified water, magnetic particles in fluid form, and materials for columns for the purpose of purification, lysis, modification and manipulation of cells, as well as for the performance of marking, separation, isolation, purification, amplification and analytical methods for biopolymers, in particular nucleic acids, enzymes, proteins, macro molecules and biologically active substances for separation, analysis and purification of biological and biochemical compounds, all of the foregoing for medical and veterinary purposes; Products for medical and veterinary medical purposes, namely, chemical, biochemical and biotechnological products as well as ] kits comprising products for medical and veterinary medical purposes, in particular chemical, biochemical and biotechnological products for sample preparation, purification, lysis, modification and manipulation of cells, as well as for the performance of marking, separation, isolation, purification, amplification and analytical methods for biopolymers, in particular nucleic acids for medical and veterinary medical purposes, enzymes, natural and artificial proteins, macro molecules, and biologically active substances for detecting pathogens, genetic information and conditions of the human bodyACTIVE—
009Scientific apparatus, instruments and equipment for research and examination purposes, [ namely, laboratory equipment, ] namely, chromatography columns; automated laboratory equipment, namely, [ robots and ] spare parts and add-ons therefor, [ namely, preprogrammed smart cards for DNA purification protocols; laboratory equipment, namely, microplates; laboratory equipment, namely, pipettes, pipette tips and pipette tip holders; laboratory equipment, namely, sample containers, reagent holders, flasks, reagent tube holders, holders for micro containers, magnetic syringes, biochips for the purpose of screen large numbers of biological analytes, thermocyclers for the purpose of performing polymerase chain reactions, homogenizers for the purpose of breaking up cell membranes and mixing the resulting liquids, and vacuum valves for the purpose of permitting the operation of laboratory processes under subatmospheric pressure, ] all of the aforementioned being included in this class and being for scientific research and examination purposesACTIVE—
042[ Scientific research for others in the fields of chemistry, genetics, biology and biochemistry; Scientific diagnostic services for others in the fields of DNA, RNA and protein detection and analysis; Research services in the field of forensic science, namely, analysis, detection and isolation of biological substances in forensic samples ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 26, 2019INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Jun 22, 2019INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Oct 22, 2018NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Oct 22, 201871AGREGISTERED-SEC.71 ACCEPTED—
Oct 12, 2018ES71TEAS SECTION 71 RECEIVED—
Oct 21, 2017REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
May 25, 2017RNWLINTERNATIONAL REGISTRATION RENEWED—
Sep 11, 2015INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Aug 18, 2015INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Aug 18, 2015INPCINVALIDATION PROCESSED—
Jun 28, 2015INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Oct 28, 2014NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Oct 28, 2014C75PREGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.—
Oct 28, 2014APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 20, 2014ES75TEAS SECTION 71 & 15 RECEIVED—
Jan 6, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 3, 2009FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 3, 2009FIMPFINAL DISPOSITION PROCESSED—
Jan 21, 2009FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 14, 2009ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 14, 2009REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 21, 2008R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 5, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 16, 2008NPUBNOTICE OF PUBLICATION—
Jun 30, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 24, 2008ALIEASSIGNED TO LIE—
Jun 24, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 20, 2008DOCKASSIGNED TO EXAMINER—
Jun 9, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 9, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 9, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 10, 2008ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 10, 2008REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 29, 2007RFNTREFUSAL PROCESSED BY IB—
Dec 12, 2007RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 11, 2007RFRRREFUSAL PROCESSED BY MPU—
Dec 11, 2007RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 10, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 30, 2007DOCKASSIGNED TO EXAMINER—
Nov 30, 2007NWAPNEW APPLICATION ENTERED—
Nov 29, 2007REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance